ABSTRACT
Hydroxychloroquine is an immunomodulatory drug that has been used for 60 years to treat malaria and autoimmune diseases such as systemic lupus erythematosus and inflammatory arthritis, and potential new uses and benefits continue to emerge. Toxicity concerns have been addressed with updated prescribing recommendations.
Footnotes
The authors declare no commercial or financial conflicts of interest relative to this article. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the US Department of the Army, Department of the Air Force, the Uniformed Services University, the Department of Defense, or the US government.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.
- Eugen Alexander Shippey III, MD⇑
- ADDRESS:
Eugen Alexander Shippey III, MD, Department of Internal Medicine, William Beaumont Army Medical Center, 170 West Castellano Drive, Apt. 7120, El Paso, TX 79912; eugen.shippey{at}gmail.com
- Vanya D. Wagler, DO, FACP, FACR
- Angelique N. Collamer, MD, FACP, FACR
ABSTRACT
Hydroxychloroquine is an immunomodulatory drug that has been used for 60 years to treat malaria and autoimmune diseases such as systemic lupus erythematosus and inflammatory arthritis, and potential new uses and benefits continue to emerge. Toxicity concerns have been addressed with updated prescribing recommendations.
Footnotes
The authors declare no commercial or financial conflicts of interest relative to this article. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the US Department of the Army, Department of the Air Force, the Uniformed Services University, the Department of Defense, or the US government.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.